Works matching IS 02683369 AND DT 2002 AND VI 30 AND IP 10

Results: 13

Unrelated donor BMT recipients given pretransplant low-dose antithymocyte globulin have outcomes equivalent to matched sibling BMT: a matched pair analysis.

Published in:

Bone Marrow Transplantation, 2002, v. 30, n. 10, p. 681

By:

Duggan, P;
Booth, K;
Chaudhry, A;
Stewart, D;
Ruether, J D;
Glück, S;
Morris, D;
Brown, C B;
Herbut, B;
Coppes, M;
Anderson, R;
Wolff, J;
Egeler, M;
Desai, S;
Turner, A R;
Larratt, L;
Gyonyor, E;
Russell, J A

Publication type:

Article

Outcome of 5651 hematopoietic stem cell transplants for hematological malignancies carried out in Europe in 1993: a reliability study of the registry.

Published in:

Bone Marrow Transplantation, 2002, v. 30, n. 10, p. 637

By:

Fouillard, L;
Labopin, M;
Gratwohl, A;
Powles, R;
Bacigalupo, A;
Bego, G;
Chesnel, V;
Gorin, N C

Publication type:

Article

Long-term follow-up of normal peripheral blood progenitor cell donors treated with filgrastim: no evidence of increased risk of leukemia development.

Published in:

Bone Marrow Transplantation, 2002, v. 30, n. 10, p. 661, doi. 10.1038/sj.bmt.1703693

By:

Anderlini, P;
Chan, F A;
Champlin, R E;
Körbling, M;
Strom, S S

Publication type:

Article

Reduced intensity preparative regimens for allogeneic hematopoietic stem cell transplantation: a single center experience.

Published in:

Bone Marrow Transplantation, 2002, v. 30, n. 10, p. 651, doi. 10.1038/sj.bmt.1703697

By:

Basara, N;
Roemer, E;
Kraut, L;
Guenzelmann, S;
Schmetzer, B;
Kiehl, M G;
Fauser, A A

Publication type:

Article

A phase I dose-escalation study of etoposide continuous infusion added to busulphan/cyclophosphamide as conditioning prior to autologous or allogeneic stem cell transplantation.

Published in:

Bone Marrow Transplantation, 2002, v. 30, n. 10, p. 645, doi. 10.1038/sj.bmt.1703698

By:

Ritchie, D S;
Szer, J;
Roberts, A W;
Shuttleworth, P;
Grigg, A P

Publication type:

Article

Successful bone marrow transplantation from an unrelated donor in a patient with adult T cell leukemia.

Published in:

Bone Marrow Transplantation, 2002, v. 30, n. 10, p. 699, doi. 10.1038/sj.bmt.1703702

By:

Ogata, M;
Ogata, Y;
Imamura, T;
Ohtsuka, E;
Kikuchi, H;
Utsunomiya, A;
Yashiki, S;
Sonoda, S;
Nasu, M

Publication type:

Article

Polymorphisms of transforming growth factor-β1 and transforming growth factor-β1 type II receptor genes are associated with acute graft-versus-host disease in children with HLA-matched sibling bone marrow transplantation.

Published in:

Bone Marrow Transplantation, 2002, v. 30, n. 10, p. 665, doi. 10.1038/sj.bmt.1703684

By:

Hattori, H;
Matsuzaki, A;
Suminoe, A;
Ihara, K;
Nagatoshi, Y;
Sakata, N;
Kawa, K;
Okamura, J;
Hara, T

Publication type:

Article

Response to induction chemotherapy is not essential to obtain survival benefit from high-dose melphalan and autotransplantation in myeloma.

Published in:

Bone Marrow Transplantation, 2002, v. 30, n. 10, p. 673, doi. 10.1038/sj.bmt.1703717

By:

Singhal, S;
Powles, R;
Sirohi, B;
Treleaven, J;
Kulkarni, S;
Mehta, J

Publication type:

Article

Generation of alloreactive anti-leukemic cytotoxic T lymphocytes with attenuated GVHD properties from haploidentical parents in childhood acute lymphoblastic leukemia.

Published in:

Bone Marrow Transplantation, 2002, v. 30, n. 10, p. 687, doi. 10.1038/sj.bmt.1703718

By:

Jurickova, I;
Waller, E K;
Yeager, A M;
Boyer, M W

Publication type:

Article

Treatment of gonadal damage in recipients of allogeneic or autologous transplantation for haematological malignancies.

Published in:

Bone Marrow Transplantation, 2002, v. 30, n. 10, p. 629, doi. 10.1038/sj.bmt.1703721

By:

Chatterjee, R;
Kottaridis, P D

Publication type:

Article

Rapid-onset leucodrema associated with graft-versus-host disease.

Published in:

Bone Marrow Transplantation, 2002, v. 30, n. 10, p. 705, doi. 10.1038/sj.bmt.1703724

By:

Jacobsohn, D A;
Ruble, K;
Moresi, J M;
Vogelsang, G B

Publication type:

Article

Pre-transplant positron emission tomography (PET) using fluorine-18-fluoro-deoxyglucose (FDG) predicts outcome in patients treated with high-dose chemotherapy and autologous stem cell transplantation for non-Hodgkin's lymphoma.

Published in:

Bone Marrow Transplantation, 2002, v. 30, n. 10, p. 707, doi. 10.1038/sj.bmt.1703726

By:

Cremerius et al

Publication type:

Article

The effect of post-transplant spironolactone on daily potassium requirements in patients undergoing autologous stem cell transplantation.

Published in:

Bone Marrow Transplantation, 2002, v. 30, n. 10, p. 703, doi. 10.1038/sj.bmt.1703728

By:

Demirer, T;
Ayli, M;
Dagli, M;
Fen, T;
Haznedar, R;
Ustael, N;
Ustun, T;
Oymak, A;
Ozdel, O;
Muftuoglu, O

Publication type:

Article